Scarica l'app Stockscreener
2.185
3.07%
0.065
Precedente Chiudi:
$2.12
Aprire:
$2.13
Volume 24 ore:
8,942
Relative Volume:
0.14
Capitalizzazione di mercato:
$106.91M
Reddito:
$63.69M
Utile/perdita netta:
$-44.82M
Rapporto P/E:
-1.0925
EPS:
-2
Flusso di cassa netto:
$-30.56M
1 W Prestazione:
-2.02%
1M Prestazione:
-0.68%
6M Prestazione:
-5.00%
1 anno Prestazione:
-3.74%
Intervallo 1D:
$2.0689
$2.23
Intervallo di 1 settimana:
$2.0689
$2.32
Portata 52W:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Nome
Mdxhealth Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MDXH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.20 | 106.91M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
426.66 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.66 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
541.00 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.57 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
163.73 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Iniziato | Lake Street | Buy |
| 2023-05-31 | Iniziato | TD Cowen | Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
Mdxhealth Sa Borsa (MDXH) Ultime notizie
Citadel Advisors LLC Sells 40,324 Shares of MDxHealth SA (NASDAQ:MDXH) - Defense World
mdxhealth sa reschedules extraordinary general meeting for june 27 By Investing.com - Investing.com India
mdxhealth sa reschedules extraordinary general meeting for june 27 - Investing.com
MDxHealth Schedules Second EGM for Share Option Plan Approval - TipRanks
Northern Trust Corp Takes $1.03 Million Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth (NASDAQ:MDXH) Upgraded to Hold at Wall Street Zen - Defense World
What is William Blair’s Forecast for MDxHealth Q3 Earnings? - Defense World
MDxHealth SA (NASDAQ:MDXH) Q1 2025 Earnings Call Transcript - Insider Monkey
MDxHealth Earnings Call: Growth Amid Financial Challenges - TipRanks
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth Reports Strong Q1 2025 Revenue Growth - TipRanks
MDxHealth ADR earnings missed by $0.01, revenue topped estimates - Investing.com India
MDxHealth SA reports results for the quarter ended March 31Earnings Summary - TradingView
MDxHealth Reports Q1 2025 Financial Results with Increased Revenue but Continued Losses - TipRanks
MDxHealth Reports Q1-2025 Results - The Manila Times
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead o - GuruFocus
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
MDXHEALTH SA Earnings Preview: Recent $MDXH Insider Trading, Hedge Fund Activity, and More - Nasdaq
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Wednesday - Defense World
MDxHealth Reports Strong Financial Turnaround in 2024 - TipRanks
Renaissance Technologies LLC Boosts Stake in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth Schedules Key Shareholders’ Meetings for May 2025 - TipRanks
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 - The Manila Times
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 | Nation/World | bdtonline.com - Bluefield Daily Telegraph
MDxHealth SA Announces Promising Research Results with New Liquid Biopsy Test in Development - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
Oppenheimer & Co. Inc. Has $47,000 Holdings in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Mdxhealth Sa Azioni (MDXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.34%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):